GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, ...

The vote, 14 to 0 with one abstention, could lift sales for the three RSV vaccine makers: GSK Plc, Pfizer Inc. and Moderna ...

It was followed by rival GSK, which tumbled 5.7 per cent, or 76.5p, to 1264p. The slump in drugmakers’ stocks came after the US president said overnight that the US would soon introduce a ...

GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education, outreach and access These grants are part of GSK’s COiMMUNITY ...

Goodwill San Francisco Bay, a local unit of the nationwide clothing-and-jobs charity network, plans to shutter its San Francisco headquarters and close its by-the-pound store in Oakland.

South Carolina is selling the longtime headquarters of its Department of Mental Health. Provided Google Maps State officials have put the building that houses the South Carolina Department of ...

The viral graphic states that the announcement comes two days after PM Modi's meeting with RSS in Nagpur on April 6 Prashant Tamta Updated : Apr 07, 2025, 08:53 PM IST A graphic with an English news ...

On April 3, 2025, GlaxoSmithKline (GSK) and Pfizer filed a stipulation to dismiss with prejudice GSK’s litigation in the United States District Court for the District of Delaware. GSK filed suit ...

COLUMBUS, Ohio — Ohio Attorney General Dave Yost is pushing to take a leading role in a federal securities lawsuit that accuses pharmaceutical giant GSK, formerly GlaxoSmithKline, of concealing the ...

South Ko­re­an biotech ABL Bio has lined up an­oth­er plat­form li­cense agree­ment with a Eu­ro­pean phar­ma gi­ant in the area of neu­rode­gen­er­a­tive dis­eases.

Big pharmaceutical companies have been making deals for technologies that could help them get their molecules through this protective membrane and now GSK is joining in, striking up an alliance ...

GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South Korean company’s tech to bypass the blood-brain barrier. ABL Bio has ...